Bridging drug discovery and clinical development
The translational research stage of R&D takes promising drug candidates from drug discovery to early clinical development.
We work with our partners to assess the safety and tolerability of new drug candidates, develop drug formulations, establish dosing requirements, and study the risk of potential interactions with other drugs, before moving to Phase I studies in healthy human volunteers. A promising compound that successfully passes these early drug development steps can then advance to Phase II proof-of-concept studies in a limited number of patients to assess whether the drug has the desired effect on the target disease.
Get our latest news, personal stories, research articles, and job opportunities.